The quadrivalent human papillomavirus vaccine: potential factors in effectiveness. [electronic resource]
Producer: 20080814Description: 188-194 p. digitalISSN:- 1542-2011
- Cost-Benefit Analysis
- Female
- Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
- Humans
- Papillomavirus Infections -- complications
- Papillomavirus Vaccines -- economics
- Practice Guidelines as Topic
- Randomized Controlled Trials as Topic
- Uterine Cervical Neoplasms -- prevention & control
- Vaginal Smears
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.